Entering text into the input field will update the search result below
Try for free
Search for Symbols, analysts, keywords

BDRX receives Nasdaq delisting notice, plans to appeal decision

Jun. 15, 2023 5:57 PM ETBiodexa Pharmaceuticals Plc (BDRX)By: Vansh Agarwal, SA News Editor
  • Biodexa Pharmaceuticals (NASDAQ:BDRX) said on Thursday that Nasdaq had notified the company of its intent to delist its stock due to BDRX's stock having had a close bid price below $0.10 for ten consecutive trading days.
  • BDRX's also fails to satisfy Nasdaq's requirement that the closing bid price of its stock remain at $1.00 or higher.
  • The company plans to appeal Nasdaq's determination to a hearings panel.
  • Press Release 

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.